Dependence on morphine leads to a prominent sharing among the different mechanisms of long-term potentiation in the CA1 region of rat hippocampus

Brain Research

Volumn 963, Issue 1-2, 2003, Pages 93-100

  Salmanzadeh, Fereshteh ^a   Fathollahi, Yaghoub ^a   Semnanian, Saeed ^a   Shafizadeh, Mahshid ^b   Kazemnejad, Anoushirvan ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Addiction; Brain slice; N Methyl D aspartate; Synaptic plasticity; Voltage dependent Ca2+ channel

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; COGNITION; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MEMORY; MORPHINE DEPENDENCE; RATS; SUBSTANCE WITHDRAWAL SYNDROME; SYNAPSES; VERAPAMIL;

EID: 0037435974     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03947-1     Document Type: Article

References (46)

1. Abraham W.C., Bear M.F. Metaplasticity: the plasticity of synaptic plasticity. Trends. Neurosci. 19:1996;126-130.
2. Antkiewicz-Michaluk L., Michaluk J., Romanska I., Vetulani J. Cortical dihydropyridine binding sites and a behavioral syndrome in morphine-abstinent rats. Eur. J. Pharmacol. 180:1990;129-135.
3. Antkiewicz-Michaluk L. Voltage-operated calcium channels: characteristics and their role in the mechanism of action of psychotropic drugs. Pol. J. Pharmacol. 51:1999;179-186.
4. Badawy A.A., Evans C.M., Evans M. Production of tolerance and physical dependence in the rat by simple administration of morphine in drinking water. Br. J. Pharmacol. 75:1982;485-491.
5. Bespalov A.Y., Balster R.L., Beardsley P.M. N-Methyl-D-aspartate receptor antagonists and the development of tolerance to the discriminative stimulus effects of morphine in rats. J. Pharmacol. Exp. Ther. 290:1999;20-27.
6. Bhargava H.N., Reddy P.L., Gudehithlu K.P. Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine. Gen. Pharmacol. 26:1995;131-136.
7. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
8. Bramham C.R. Opioid receptor dependent long-term potentiation: Peptidergic regulation of synaptic plasticity in the hippocampus. Neurochem. Int. 20:1992;441-455.
9. Borroni A.M., Fichtenholtz H., Woodside B.L., Teyler T.J. Role of voltage-dependent calcium channel long-term potentiation (LTP) and NMDA LTP in spatial memory. J. Neurosci. 20:2000;9272-9276.
10. Cavus I., Teyler T.J. NMDA receptor-independent LTP in basal versus apical dendrites of CA1 pyramidal cells in rat hippocampal slice. Hippocampus. 8:1998;373-379.
11. Cebers G., Cebere A., Kovacs A.D., Hogberg H., Moreira T., Liljequist S. Increased ambient glutamate concentration alters the expression of NMDA receptor subunits in cerebellar granule neurons. Neurochem. Int. 39:2001;151-160.
12. Dravolina O.A., Belozertseva I.V., Sukhotina I.A., Bespalov A.Y. Morphine tolerance and dependence in mice with history of repeated exposures to NMDA receptor channel blockers. Pharmacol. Bichem. Behav. 63:1999;613-619.
13. Eisch A.J., Barrot M., Schad C.A., Self D.W., Nestler E.J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. USA. 97:2000;7579-7584.
14. Fan G.H., Wang L.Z., Qiu H.C., Ma L., Pei G. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 56:1999;39-45.
15. Fitzgerald L.W., Ortiz J., Hamedani A.G., Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16:1996;274-282.
16. Foster T.C. Involvement of hippocampal synaptic plasticity in age related memory decline. Brain Res. Rev. 30:1999;236-249.
17. Fundytus M.E., Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113:1994;1215-1220.
18. Gonzalez P., Cabello P., Germany A., Norris B., Contreras E. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur. J. Pharmacol. 332:1997;257-262.
19. Grover L.M., Teyler T.J. Two components of long-term potentiation induced by different patterns of afferent activation. Nature. 347:1990;477-479.
20. Jones R.S., Heinemann U. Verapamil blocks the after hyperpolarization but not the spike frequency accommodation of rat CA1 pyramidal cells in vitro. Brain Res. 462:1988;367-371.
21. Leung L.S., Ambrose S.A.V. Long-term potentiation as a function of test pulse intensity: A study using input/output profiles. Brain Res. Bull. 33:1994;453-460.
22. Littleton J., Brennan C. Adaptive changes in numbers of calcium channels in drug dependence. Biochem. Soc. Symp. 59:1993;193-203.
23. Manning B.H., Mao J., Frenk H., Price D.D., Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain. 67:1996;79-88.
24. Mansouri F.A., Motamedi F., Fathollahi Y., Atapour N., Semnanian S. Augmentation of LTP induced by primed-bursts tetanic stimulation in hippocampal CA1 area of morphine dependent rats. Brain Res. 769:1997;119-124.
25. Mansouri F.A., Motamedi F., Fathollahi Y. Chronic in vivo morphine administration facilitates primed-bursts-induced long-term potentiation of Schaffer collateral-CA1 synapses in hippocampal slices in vitro. Brain Res. 815:1999;419-423.
26. Martin G., Ahmed S.H., Blank T., Spiess J., Koob G.F., Siggins G.R. Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens. J. Neurosci. 19:1999;9081-9089.
27. McEachern J.C., Shaw C.A. An alternative to the LTP orthodoxy: a plasticity-pathology continuum model. Brain Res. Rev. 22:1996;51-92.
28. Morgan S.L., Teyler T.J. VDCCs and NMDARs underlie two forms of LTP in CA1 hippocampus in vivo. J. Neurophysiol. 82:1999;736-740.
29. Otto T., Eichenbaum H., Wiener S.I., Wible C.G. Learning-related patterns of CA1 spike trains parallel stimulation parameters optimal for inducing hippocampal long-term potentiation. Hippocampus. 1:1991;181-192.
30. Popik P., Danysz W. Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine. J. Pharmacol. Exp. Ther. 280:1997;854-865.
31. Potier B., Rascol O., Lamour Y., Dutar P. Effect of verapamil independent of its calcium channel antagonist action on hippocampal pyramidal neurons in rat. C. R. Acad. Sci. 311:1990;89-94.
32. Pourmotabbed A., Motamedi F., Fathollahi Y., Mansouri F.A., Semnanian S. Involvement of NMDA receptors and voltage-dependent calcium channels on augmentation of long-term potentiation in hippocampal CA1 area of morphine dependent rats. Brain Res. 804:1998;125-134.
33. Pu L., Bao G.B., Xu N.J., Ma L., Pie G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. J. Neurosci. 22:2002;1914-1921.
34. Racz B., Fuzesi M., Halasy K. The hippocampal opioidergic system: A comparative immunocytochemical study in four rodents. Neurobiology. 6:1998;429-441.
35. Ramkumar V., El-Fakahany E.E. Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence. Eur. J. Pharmacol. 146:1988;73-83.
36. Rascol O., Potier B., Lamour Y., Dutar P. Effects of calcium channel agonist and antagonists on calcium-dependent events in CA1 hippocampal neurons. Fundam. Clin. Pharmacol. 5:1991;299-317.
37. Robinson J.H., Deadwyler S.A. Morphine excitation: effects on field potentials recorded in the in vitro hippocampal slice. Neuropharmacology. 19:1980;507-514.
38. Sala M.M., Braida D.D., Leone M.M., Calcaterra P.P., Frattola D.D., Gori E.E. Chronic morphine affects working memory during treatment and withdrawal in rats: possible residual long-term impairment. Behav. Pharmacol. 5:1994;570-580.
39. Satoh M., Minami M. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68:1995;343-364.
40. Shankar S., Teyler T.J., Robbins N. Aging differentially alters forms of long-term potentiation in rat hippocampal area CA1. J. Neurophysiol. 79:1998;334-341.
41. Simmons M.L., Chavkin C. Endogenous opioid regulation of hippocampal function. Int. Rev. Neurobiol. 39:1996;145-196.
42. Spain J.W., Newsom G.C. Chronic opioids impair acquisition of both radial maze and Y maze choice escape. Psychopharmacology. 105:1991;101-106.
43. Su M.T., Lin W.B., Lue W.M., Cheng C.Y., Tao P.L. Blockade of the development of morphine tolerance by U-50,488, an AVP antagonist or MK-801 in the rat hippocampal slice. Br. J. Pharmacol. 123:1998;625-630.
44. Swearengen E., Chavkin C. Comparison of opioid and GABA receptor control of excitability and membrane conductance in hippocampal CA1 pyramidal cells in rat. Neuropharmacology. 28:1989;689-697.
45. Velisek L., Stanton P.K., Moshe S.I., Vathy I. Prenatal morphine exposure enhances seizure susceptibility but suppresses long-term potentiation in the limbic system of adult male rats. Brain Res. 869:2000;186-193.
46. Wimpey T.L., Caudle R.M., Chavkin C. Chronic morphine exposure blocks opioid effects on both the early and late inhibitory postsynaptic potentials in hippocampal CA1 pyramidal cells. Neurosci. Lett. 110:1990;349-355.